| Single-dose liposomal amphotericin B treatment for cryptococcal meningitis JN Jarvis, DS Lawrence, DB Meya, E Kagimu, J Kasibante, E Mpoza, ... New England Journal of Medicine 386 (12), 1109-1120, 2022 | 220 | 2022 |
| Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study J Rhein, BM Morawski, KH Hullsiek, HW Nabeta, R Kiggundu, L Tugume, ... The Lancet infectious diseases 16 (7), 809-818, 2016 | 197 | 2016 |
| Improved diagnostic sensitivity for tuberculous meningitis with Xpert® MTB/RIF of centrifuged CSF NC Bahr, L Tugume, R Rajasingham, R Kiggundu, DA Williams, ... The international journal of tuberculosis and lung disease 19 (10), 1209-1215, 2015 | 142 | 2015 |
| Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial J Rhein, KH Hullsiek, L Tugume, E Nuwagira, E Mpoza, EE Evans, ... The Lancet infectious diseases 19 (8), 843-851, 2019 | 119 | 2019 |
| Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study FV Cresswell, L Tugume, NC Bahr, R Kwizera, AS Bangdiwala, ... The Lancet infectious diseases 20 (3), 308-317, 2020 | 116 | 2020 |
| The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes JA Seddon, L Tugume, R Solomons, K Prasad, NC Bahr, ... Wellcome open research 4, 167, 2019 | 113 | 2019 |
| High-dose oral and intravenous rifampicin for the treatment of tuberculous meningitis in predominantly human immunodeficiency virus (HIV)-positive Ugandan adults: a phase II … FV Cresswell, DB Meya, E Kagimu, D Grint, L Te Brake, J Kasibante, ... Clinical Infectious Diseases 73 (5), 876-884, 2021 | 70 | 2021 |
| Detrimental outcomes of unmasking cryptococcal meningitis with recent ART initiation J Rhein, KH Hullsiek, EE Evans, L Tugume, E Nuwagira, ... Open forum infectious diseases 5 (8), ofy122, 2018 | 65 | 2018 |
| Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics PS Ramachandran, A Ramesh, FV Creswell, A Wapniarski, R Narendra, ... Nature communications 13 (1), 1675, 2022 | 60 | 2022 |
| The changing epidemiology of HIV-associated adult meningitis, Uganda 2015–2017 J Ellis, AS Bangdiwala, FV Cresswell, J Rhein, E Nuwagira, ... Open forum infectious diseases 6 (10), ofz419, 2019 | 60 | 2019 |
| HIV-associated cryptococcal meningitis occurring at relatively higher CD4 counts L Tugume, J Rhein, KH Hullsiek, E Mpoza, R Kiggundu, ... The Journal of infectious diseases 219 (6), 877-883, 2019 | 57 | 2019 |
| Treatment outcomes in adult tuberculous meningitis: a systematic review and meta-analysis AM Stadelman, J Ellis, THA Samuels, E Mutengesa, J Dobbin, ... Open forum infectious diseases 7 (8), ofaa257, 2020 | 52 | 2020 |
| Cryptococcal meningitis L Tugume, K Ssebambulidde, J Kasibante, J Ellis, RM Wake, J Gakuru, ... Nature reviews Disease primers 9 (1), 62, 2023 | 45 | 2023 |
| Symptomatic cryptococcal antigenemia presenting as early cryptococcal meningitis with negative cerebral spinal fluid analysis K Ssebambulidde, AS Bangdiwala, R Kwizera, TK Kandole, L Tugume, ... Clinical infectious diseases 68 (12), 2094-2098, 2019 | 38 | 2019 |
| Oral lipid nanocrystal amphotericin B for cryptococcal meningitis: a randomized clinical trial DR Boulware, M Atukunda, E Kagimu, AK Musubire, A Akampurira, ... Clinical Infectious Diseases 77 (12), 1659-1667, 2023 | 32 | 2023 |
| Evaluation of a point-of-care immunoassay test kit ‘StrongStep’for cryptococcal antigen detection E Mpoza, L Mukaremera, DA Kundura, A Akampurira, T Luggya, ... PLoS One 13 (1), e0190652, 2018 | 32 | 2018 |
| Standardized urine-based tuberculosis (TB) screening with TB-lipoarabinomannan and Xpert MTB/RIF Ultra in Ugandan adults with advanced human immunodeficiency virus disease and … FV Cresswell, J Ellis, E Kagimu, AS Bangdiwala, M Okirwoth, G Mugumya, ... Open forum infectious diseases 7 (4), ofaa100, 2020 | 28 | 2020 |
| Cerebrospinal fluid early fungicidal activity as a surrogate endpoint for cryptococcal meningitis survival in clinical trials MF Pullen, KH Hullsiek, J Rhein, AK Musubire, L Tugume, E Nuwagira, ... Clinical Infectious Diseases 71 (7), e45-e49, 2020 | 26 | 2020 |
| Parasites and their protection against COVID-19-Ecology or Immunology? K Ssebambulidde, I Segawa, KM Abuga, V Nakate, A Kayiira, J Ellis, ... MedRxiv, 2020.05. 11.20098053, 2020 | 26 | 2020 |
| Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitis L Tugume, BM Morawski, M Abassi, NC Bahr, R Kiggundu, HW Nabeta, ... HIV medicine 18 (1), 13-20, 2017 | 26 | 2017 |
David R BoulwareProfessor of Medicine, University of MinnesotaEmail verificata su Umn.edu